111 Capital’s Eastman Chemical EMN Stock Holding History

111 Capital’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,756	Closed	-$504K	–	532
2025 Q2	$504K	Buy	+6,756	New	+$531K	0.09%	258

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

111 Capital's EMN Position: Q3 2025 in Review

111 Capital sold out of Eastman Chemical (EMN) in Q3 2025, closing a stake of 6,756 shares — an estimated $504K sold.

111 Capital first reported a position in EMN in Q2 2025 and held it in 1 quarter. The position peaked at $504K in Q2 2025. 663 funds tracked by Wall St. Rank hold EMN as of Q3 2025.

111 Capital reported no remaining Eastman Chemical position as of Q3 2025 after selling out during the quarter.
111 Capital sold 6,756 Eastman Chemical shares in Q3 2025, an estimated $504K.
111 Capital first reported a position in Eastman Chemical in Q2 2025 and held it in 1 quarter.
111 Capital's Eastman Chemical position peaked at $504K in Q2 2025.
663 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2025.

Based on 111 Capital's 13F filing for Q3 2025, filed 12 Nov 2025.